Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2002-12-18
2008-11-18
Aulakh, Charanjit S (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S137000
Reexamination Certificate
active
07452904
ABSTRACT:
Carbamate of general formula (I), wherein R1, R2, and R3 are H, OH, NO2, SH, CN, F, Cl, Br, I, COOH, CONH2, (C1-C4)-alkoxycarbonyl, (C1-C4)-alkylsulfanyl, (C1-C4)-alkylsulfinyl, (C1-C4)-alkylsulfonyl, (C1-C4)-alkoxyl optionally substituted with one or several F, and (C1-C4)-alkyl optionally substituted with one or several F or OH; R4 is cycloalkyl, phenyl, heteroaryl or a bicyclic ring system; R5 is cycloalkyl, (C5-C10)-alkyl, a substituted (C1-C10)-alkyl; and X−is a physiologically acceptable anion. Carbamate (I) is selective M3receptor antagonists versus M2receptor and may be used for the treatment of urinary incontinence (particularly, the one caused by overactive bladder), irritable bowel syndrome, and respiratory disorders (particularly, chronic obstructive pulmonary disease, chronic bronchitis, asthma, emphysema, and rhinitis), as well as in ophthalmic interventions.
REFERENCES:
patent: 6916828 (2005-07-01), Farrerons Gallemi et al.
patent: 7115629 (2006-10-01), Farrerons Gallemi et al.
patent: 7208501 (2007-04-01), Buil Albero et al.
patent: 0 747 355 (1996-12-01), None
patent: 0 801 067 (1997-10-01), None
patent: 01/04118 (2001-01-01), None
patent: WO 02/051841 (2001-12-01), None
patent: 02/051841 (2002-07-01), None
Balsa Lopez Dolors
Catena Ruiz Juan Lorenzo
Farrerons Gallemi Carles
Fernandez Garcia Andres
Fernandez Serrat Anna
Aulakh Charanjit S
Chiesi Farmaceutici S.p.A.
Merchant & Gould P.C.
LandOfFree
1-alkyl-1-azoniabicyclo' 2.2.2 octane carbamate derivatives... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-alkyl-1-azoniabicyclo' 2.2.2 octane carbamate derivatives..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-alkyl-1-azoniabicyclo' 2.2.2 octane carbamate derivatives... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4030576